Basilea Pharmaceutica AG (SWX:BSLN)
47.60
-0.40 (-0.83%)
Jun 27, 2025, 5:31 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 583.96 million as of June 27, 2025. Its market cap has increased by 15.59% in one year.
Market Cap
583.96M
Enterprise Value
574.92M
Revenue
208.54M
Ranking
n/a
PE Ratio
8.17
Stock Price
47.60
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 583.96M, an increase of 9.50%. That is a compound annual growth rate of 0.43%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 210.13B |
Novartis AG | 188.13B |
Lonza Group AG | 40.02B |
Alcon | 34.88B |
Galderma Group AG | 28.13B |
Sandoz Group AG | 18.49B |
Straumann Holding AG | 16.42B |
Sonova Holding AG | 14.23B |